Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Shares of Tango Therapeutics Climbed This Week
Why Shares of Tango Therapeutics Climbed This Week
Why Shares of Tango Therapeutics Climbed This Week
Submitted by
admin
on September 14, 2023 - 10:56pm
Source:
Motley Fool
News Tags:
Tango Therapeutics
CRISPR
gene editing
clinical trials
Headline:
Why Shares of Tango Therapeutics Climbed This Week
snippet:
Tango said it has $310.7 million in cash, enough to fund operations into 2026.
The company has several early-stage trials.
Tango focuses on CRISPR gene-editing therapies to treat cancer.
Do Not Allow Advertisers to Use My Personal information
